During the past decade, Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi" #1 sponsor was "Janssen Research & Development, LLC" with 9 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Bayer" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Crohn Disease" (3 trials), "Neoplasm Metastasis" (3 trials), "Breast Neoplasms" (2 trials) and "Prostatic Neoplasms" (2 trials). Many other conditions were trialed in "Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi" in a lesser frequency.

Most popular intervention types in "Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi" are "Drug" (26 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Amivantamab" (4 trials), "Carboplatin" (4 trials), "Abemaciclib" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi" are 21 trials for "All" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi". undefined are not yet recruiting, 20 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".